Diseases

Explore disease pages that summarize symptoms, diagnostic context, and related care topics.

Featured: 100

Browse A-Z

Page 161 of 740

All diseases (73,990)

T467X3A

Poisoning by peripheral vasodilators, assault, initial encounter

T467X3D

Poisoning by peripheral vasodilators, assault, subsequent encounter

T467X3S

Poisoning by peripheral vasodilators, assault, sequela

T467X4A

Poisoning by peripheral vasodilators, undetermined, initial encounter

T467X4D

Poisoning by peripheral vasodilators, undetermined, subsequent encounter

T467X4S

Poisoning by peripheral vasodilators, undetermined, sequela

T467X5A

Adverse effect of peripheral vasodilators, initial encounter

T467X5D

Adverse effect of peripheral vasodilators, subsequent encounter

T467X5S

Adverse effect of peripheral vasodilators, sequela

T467X6A

Underdosing of peripheral vasodilators, initial encounter

T467X6D

Underdosing of peripheral vasodilators, subsequent encounter

T468X1A

Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter

T468X1D

Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter

T468X1S

Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela

T468X2A

Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter

T468X2D

Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter

T468X2S

Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela

T468X3A

Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter

T468X3D

Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter

T468X3S

Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela

T468X4A

Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter

T468X4D

Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter

T468X4S

Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela

T468X5A

Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter

T468X5D

Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter

T468X5S

Adverse effect of antivaricose drugs, including sclerosing agents, sequela

T468X6A

Underdosing of antivaricose drugs, including sclerosing agents, initial encounter

T468X6D

Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter

T468X6S

Underdosing of antivaricose drugs, including sclerosing agents, sequela

T46901A

Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter

T46901D

Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter

T46901S

Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela

T46902A

Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter

T46902D

Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter

T46902S

Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela

T46903A

Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter

T46903D

Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter

T46903S

Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela

T46904A

Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter

T46904D

Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter

T46904S

Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela

T46905A

Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter

T46905D

Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter

T46905S

Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela

T46906A

Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter

T46906D

Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter

T46906S

Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela

T46991A

Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter

T46991D

Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter

T46991S

Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela

T46992A

Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter

T46992D

Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter

T46992S

Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela

T46993A

Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter

T46993D

Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter

T46993S

Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela

T46994A

Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter

T46994D

Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter

T46994S

Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela

T46995A

Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter

T46995D

Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter

T46995S

Adverse effect of other agents primarily affecting the cardiovascular system, sequela

T46996A

Underdosing of other agents primarily affecting the cardiovascular system, initial encounter

T46996D

Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter

T46996S

Underdosing of other agents primarily affecting the cardiovascular system, sequela

T470X1A

Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter

T470X1D

Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter

T470X1S

Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela

T470X2A

Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter

T470X2D

Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter

T470X2S

Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela

T470X3A

Poisoning by histamine H2-receptor blockers, assault, initial encounter

T470X3D

Poisoning by histamine H2-receptor blockers, assault, subsequent encounter

T470X3S

Poisoning by histamine H2-receptor blockers, assault, sequela

T470X4A

Poisoning by histamine H2-receptor blockers, undetermined, initial encounter

T470X4D

Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter

T470X4S

Poisoning by histamine H2-receptor blockers, undetermined, sequela

T470X5A

Adverse effect of histamine H2-receptor blockers, initial encounter

T470X5D

Adverse effect of histamine H2-receptor blockers, subsequent encounter

T470X5S

Adverse effect of histamine H2-receptor blockers, sequela

T470X6A

Underdosing of histamine H2-receptor blockers, initial encounter

T470X6D

Underdosing of histamine H2-receptor blockers, subsequent encounter

T470X6S

Underdosing of histamine H2-receptor blockers, sequela

T471X1A

Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter

T471X1D

Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter

T471X1S

Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela

T471X2A

Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter

T59814S

Toxic effect of smoke, undetermined, sequela

T471X2D

Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter

T471X2S

Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela

T471X3A

Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter

T471X3D

Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter

T471X3S

Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela

T471X4A

Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter

T471X4D

Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter

T471X4S

Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela

T471X5A

Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter

T471X5D

Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter

T471X5S

Adverse effect of other antacids and anti-gastric-secretion drugs, sequela

T471X6A

Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter